TY - JOUR A1 - Munsch, Nicolas A1 - Gruarin, Stefanie A1 - Nateqi, Jama A1 - Lutz, Thomas A1 - Binder, Michael A1 - Aberle, Judith H. A1 - Martin, Alistair A1 - Knapp, Bernhard T1 - Symptoms associated with a COVID-19 infection among a non-hospitalized cohort in Vienna JF - Wiener Klinische Wochenschrift / The Central European Journal of Medicine N2 - Background: Most clinical studies report the symptoms experienced by those infected with coronavirus disease 2019 (COVID-19) via patients already hospitalized. Here we analyzed the symptoms experienced outside of a hospital setting. Methods: The Vienna Social Fund (FSW; Vienna, Austria), the Public Health Services of the City of Vienna (MA15) and the private company Symptoma collaborated to implement Vienna's official online COVID-19 symptom checker. Users answered 12 yes/no questions about symptoms to assess their risk for COVID-19. They could also specify their age and sex, and whether they had contact with someone who tested positive for COVID-19. Depending on the assessed risk of COVID-19 positivity, a SARS-CoV‑2 nucleic acid amplification test (NAAT) was performed. In this publication, we analyzed which factors (symptoms, sex or age) are associated with COVID-19 positivity. We also trained a classifier to correctly predict COVID-19 positivity from the collected data. Results: Between 2 November 2020 and 18 November 2021, 9133 people experiencing COVID-19-like symptoms were assessed as high risk by the chatbot and were subsequently tested by a NAAT. Symptoms significantly associated with a positive COVID-19 test were malaise, fatigue, headache, cough, fever, dysgeusia and hyposmia. Our classifier could successfully predict COVID-19 positivity with an area under the curve (AUC) of 0.74. Conclusion: This study provides reliable COVID-19 symptom statistics based on the general population verified by NAATs. Keywords: Chatbot; Machine learning; Self-reported; Symptom assessment; Symptom checker. KW - COVID-19 KW - Chatbot KW - Machine learning KW - Self-reported KW - Symptom assessment Y1 - VL - 2022 IS - 134 (9-10) SP - 344 EP - 350 PB - Springer ER -